1. Stocks
  2. Concord Drugs Ltd.
  3. Swot
swot-logo

Concord Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Concord Drugs Ltd. has 13 Strengths, 9 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Turnaround Potential (DVM)

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Companies with Zero Promoter Pledge

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

High PE (PE > 40)

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Declining Revenue every quarter for the past 2 quarters

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

High Delivery Percentage

Bullish or Bearish Candlestick Strength - Indices

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)

Decline in Quarterly Net Profit with falling Profit Margin (YoY)

Hammer (Bullish Reversal)